South Africa: ARV Breakthrough — Trial Confirms Effectiveness of New Drug (TLD) Anti-Retroviral ARC HIV/AIDS Medicine News Article Public Sector South Africa Southern Africa The ADVANCE study confirms that dolutegravir is an effective and well-tolerated ARV for people initiating ... HIV/AIDS News Pharmaceutical South Africa • May 30, 2026
